Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 24, 2006

View Archived Issues

Synergy seen with AT-001 and hydroxychloroquine in rheumatoid arthritis

Sitaxsentan ameliorates effects of cardioplegic arrest and cardiopulmonary bypass

Targeting Kv1.3 channels shows promise for treating autoimmune diseases

Mistletoe extract demonstrates antiangiogenic and proapoptotic activity in preclinical studies

Cardiome Pharma advances vernakalant development in third quarter

CP-690550 improves signs and symptoms of rheumatoid arthritis

Crucell completes acquisition of SBL Vaccin

Final patient treated in EDEMA3 study of DX-88 for HAE

Phase I/II study investigates Imprime PGG with G-CSF for stem cell mobilization

Contracts issued for prepandemic influenza vaccines

Synthetic human secretin improves magnetic resonance cholangiopancreatography

Study shows lenalidomide has a role in treating relapsed/refractory multiple myeloma

Novel melanocortin agonist shows efficacy in animal models of acute renal failure

Preclinical and clinical efficacy of different antiangiogenic strategies for the management of CNV

European orphan drug status for Removab antibody in gastric cancer

Galapagos and CFFT extend cystic fibrosis alliance

Nventa advances development of HspE7 following FDA meeting

ExonHit identifies companion diagnostic to assist EHT-0202 development

Cellegy's stockholders approve asset sale to ProStrakan

Betaferon approved in Australia for earliest stages of MS

Arcoxia shows similar rates of adverse cardiovascular events to diclofenac

Apricitabine has no significant adverse effect on cardiac safety

Draximage to run neuroblastoma trials of I-131 MIBG

Recent Shionogi patent discloses novel therapeutic option for HIV infection

Novel agents for dermatological disorders disclosed in recent Pfizer patent

Recent Novartis and Sankyo patents describe new treatment options for cardiovascular diseases

Gardasil available in France

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...